SCOPUS 정보 검색 플랫폼

Cancer Chemotherapy and Pharmacology

Volumn 50, Issue 1, 2002, Pages 9-15

Rapid biotransformation of satraplatin by human red blood cells in vitro

(3) Carr, Jocelyn L a Tingle, Malcolm D a McKeage, Mark J a

a UNIVERSITY OF AUCKLAND (New Zealand)

Author keywords

Biotransformation; Drug stability; ICPMS; Red blood cells; Satraplatin

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; DIACETOAMMINEDIHYDROXYCYCLOHEXYLAMINE PLATINUM; DIACETOAMMINEHYDROXYCHLOROCYCLOHEXYLAMINE PLATINUM; JM 383; JM 518; METHANOL; PLATINUM AMMINE CYCLOHEXYLAMINE DICHLORIDE; PLATINUM COMPLEX; SATRAPLATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; BODY FLUID; CELL LEVEL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STABILITY; DRUG TRANSFORMATION; ELECTROPHORETIC MOBILITY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROCYTES; HALF-LIFE; HUMANS; MASS SPECTROMETRY; ORGANOPLATINUM COMPOUNDS; PLATINUM;

EID: 0036302391 PISSN: 03445704 EISSN: None Source Type: Journal
DOI: 10.1007/s00280-002-0462-2 Document Type: Article

Times cited : (71)

References (24)

1
- 0031805023
- Phase I study of oral JM216 given twice daily
- (1998) Cancer Chemother Pharmacol , vol.42 , pp. 142
- Beale, P.¹ Raynaud, F.I.² Hanwell, J.³ Berry, C.⁴ Moore, S.⁵ O'Dell, D.E.⁶ Judson, I.R.⁷

2
- 4243932597
- The chemistry of cisplatin in aqueous solution
- Kelland LR, Farrell NP (eds). Humana Press, New Jersey
- (2000) Platinum-based drugs in cancer therapy , pp. 3
- Berners-Price, S.J.¹ Appleton, T.G.²

3
- 0002660979
- How does cisplatin kill cells?
- Kelland LR, Farrell NP (eds). Humana Press, New Jersey
- (2000) Platinum-based drugs in cancer therapy , pp. 149
- Fink, D.¹ Howell, S.B.²

4
- 0032791924
- Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer
- (1999) J Clin Oncol , vol.17 , pp. 3822
- Fokkema, E.¹ Groen, H.J.M.² Bauer, J.³ Uges, D.R.A.⁴ Weil, C.⁵ Smith, I.E.⁶

5
- 0032627429
- Quantitative determination of platinum complexes in human plasma generated from the oral antitumour drug JM216 using directly coupled high-performance liquid chromatography-inductively coupled plasma mass spectrometry without desolvation
- (1999) J Anal At Spectrom , vol.14 , pp. 953
- Galettis, P.¹ Carr, J.L.² Paxton, J.P.³ McKeage, M.J.⁴

6
- 0009720127
- 14C-JM-118 in rats and dogs
- (1998) Proc Am Assoc Cancer Res , vol.39 , pp. 525
- Gaver, R.C.¹ Blair, I.A.² Arora, V.K.³ Gale, P.J.⁴ Papp, E.⁵ Knupp, C.A.⁶

7
- 0014949453
- Inhibitory effects of antitumor platinum compounds on DNA. RNA and protein synthesis in mammalian cells in vitro
- (1970) Int J Cancer , vol.6 , pp. 207
- Harder, H.C.¹ Rosenburg, B.²

8
- 2542422438
- Structure, recognition and processing of cisplatin-DNA adducts
- (1999) Chem Rev , vol.99 , pp. 2467
- Jamieson, E.R.¹ Lippard, S.J.²

9
- 0031905499
- Sample handling for determination of free platinum in blood after cisplatin exposure
- (1998) Cancer Chemother Pharmacol , vol.41 , pp. 248
- Johnsson, A.¹ Björk, H.² Schütz, A.³ Skärby, T.⁴

10
- 0034040527
- An update on satraplatin: The first orally available platinum anticancer drug
- (2000) Exp Opin Invest Drugs , vol.9 , pp. 1373
- Kelland, L.R.¹

11
- 0033658605
- Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: A phase I study
- (2000) Jpn J Clin Oncol , vol.30 , pp. 377
- Kurata, T.¹ Tamura, T.² Sasaki, Y.³ Fujii, H.⁴ Negoro, S.⁵ Fukuoka, M.⁶ Saijo, N.⁷

12
- 0000886006
- Kinetics and mechanism for reduction of oral anticancer platinum(IV) di-carboxylate compounds by L-ascorbate ions
- (2000) J Chem Soc Dalton Trans , vol.7 , pp. 1167
- Lemma, K.¹ Sargeson, A.M.² Elding, L.I.³

13
- 0029974518
- Comparison of ethanol precipitation with plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrations
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 391
- Ma, J.¹ Stoter, G.² Verweij, J.³ Schellens, J.H.M.⁴

14
- 0029089517
- A phase I and pharmacology study of an oral platinum complex, JM216: Dose-dependant pharmacokinetics with single-dose administration
- (1995) Cancer Chemother Pharmacol , vol.36 , pp. 451
- McKeage, M.J.¹ Mistry, P.² Ward, J.³ Boxall, F.E.⁴ Loh, S.⁵ O'Neil, C.⁶ Ellis, P.⁷ Kelland, L.R.⁸ Morgan, S.E.⁹ Murrer, B.¹⁰ Santabarbara, P.¹¹ Harrap, K.R.¹² Judson, I.R.¹³

15
- 0030742993
- Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer
- (1997) J Clin Oncol , vol.15 , pp. 2691
- McKeage, M.J.¹ Raynaud, F.I.² Ward, J.³ Berry, C.⁴ O'Dell, D.E.⁵ Kelland, L.R.⁶ Murrer, B.A.⁷ Santabarbara, P.⁸ Harrap, K.R.⁹ Judson, I.R.¹⁰

16
- 0009681162
- Company Press Release
- (2001) NeoTherapeutics' NeoOncoRx acquires late-stage third-generation platinum cancer drug with broad spectrum of activity from Johnson Matthey

17
- 0009680745
- Phase II trial of oral platinum (JM216) in hormone refractory prostate cancer (HRPC)
- (1998) Proc ASCO , vol.17
- Peereboom, D.¹ Wood, L.² Connell, C.³

18
- 0028871871
- Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry
- (1995) J Chromatogr A , vol.712 , pp. 61
- Poon, G.K.¹ Raynaud, F.I.² Mistry, P.³ O'Dell, D.E.⁴ Kelland, L.R.⁵ Harrap, K.R.⁶ Barnard, C.F.⁷ Murrer, B.A.⁸

19
- 0029758018
- Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products
- (1996) Anticancer Res , vol.16 , pp. 1857
- Raynaud, F.I.¹ Boxall, F.E.² Goddard, P.³ Barnard, C.F.⁴ Murrer, B.A.⁵ Kelland, L.R.⁶

20
- 0029947258
- Biotransformation of the platinum drug JM216 following oral administration to cancer patients
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 155
- Raynaud, F.I.¹ Mistry, P.² Donaghue, A.³ Poon, G.K.⁴ Kelland, L.R.⁵ Barnard, C.F.J.⁶ Murrer, B.A.⁷ Harrap, K.R.⁸

21
- 0030055978
- Intracellular metabolism of the orally active platinum drug JM216: Influence of glutathione levels
- (1996) Br J Cancer , vol.73 , pp. 380
- Raynaud, F.I.¹ O'Dell, D.E.² Kelland, L.R.³

22
- 0032423757
- Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
- (1998) Ann Oncol , vol.9 , pp. 1315
- Sessa, C.¹ Minoia, C.² Ronchi, A.³ Zucchetti, M.⁴ Bauer, J.⁵ Borner, M.⁶ De Jong, J.⁷ Pagani, O.⁸ Renard, J.⁹ Weil, C.¹⁰ D'Incalci, M.¹¹

23
- 0026500537
- Enhanced intracellular activation of carboplatin in hemoglobin-synthesizing versus undifferentiated erythroleukemic cells
- (1992) Biochem Biophys Res Commun , vol.182 , pp. 760
- Tonetti, M.¹ Gasparini, A.² Giovine, M.³ Benatti, U.⁴ De Flora, A.⁵

24
- 0026873563
- Interaction of carboplatin with carrier human erythrocytes
- (1992) Biotech Appl Biochem , vol.15 , pp. 267
- Tonetti, M.¹ Gasparini, A.² Giovine, M.³ Bini, D.⁴ Mazzucotelli, A.⁵ De Paz, F.⁶ Benatti, U.⁷ De Flora, A.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.